Design of a phase 2 clinical program for the development of PGN-EDO51 in participants with duchenne muscular dystrophy (DMD)
Journal of the Neurological Sciences2023Vol. 455, pp. 121120–121120
Jane Larkindale, Michelle Mellion, Jennifer Cormier, S. Vacca, Jennifer Shoskes, Pallavi Lonkar, Ashling Holland, Brijesh K. Garg, James Mcarthur
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)